Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Bergeron

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Journal of Clinical Pharmacology|August 1, 1992
What preclinical data are needed to justify once-daily therapy?M G Bergeron
L'Union Medicale Du Canada|December 1, 1984
[Therapeutic attitude toward the new cephalosporins]M G Bergeron
L'Union Medicale Du Canada|February 1, 1980
[Pneumonia, clinical approach]M G Bergeron
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1995
Targeting HIV with liposome-encapsulated antiviralsA Désormeaux, M G Bergeron
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organismsP Simard, M G Bergeron
Kidney International|October 1, 1986
Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritisM G Bergeron, Y Marois
Antimicrobial Agents and Chemotherapy|January 1, 1986
Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothinM G Bergeron, Y Bergeron
Expert Review of Molecular Diagnostics|March 21, 2002
Molecular methods for rapid detection of group B streptococciD Ke, M G Bergeron
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2010
Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testingL Bissonnette, M G Bergeron
Infection|March 1, 1995
Diagnosing bacterial infectious diseases in one hour: an essential upcoming revolutionM G Bergeron, M Quellette
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Journal of Clinical Pharmacology|August 1, 1992
What preclinical data are needed to justify once-daily therapy?M G Bergeron
L'Union Medicale Du Canada|December 1, 1984
[Therapeutic attitude toward the new cephalosporins]M G Bergeron
L'Union Medicale Du Canada|February 1, 1980
[Pneumonia, clinical approach]M G Bergeron
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1995
Targeting HIV with liposome-encapsulated antiviralsA Désormeaux, M G Bergeron
The Journal of Antimicrobial Chemotherapy|November 1, 1982
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organismsP Simard, M G Bergeron
Kidney International|October 1, 1986
Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritisM G Bergeron, Y Marois
Antimicrobial Agents and Chemotherapy|January 1, 1986
Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothinM G Bergeron, Y Bergeron
Expert Review of Molecular Diagnostics|March 21, 2002
Molecular methods for rapid detection of group B streptococciD Ke, M G Bergeron
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 31, 2010
Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testingL Bissonnette, M G Bergeron
Infection|March 1, 1995
Diagnosing bacterial infectious diseases in one hour: an essential upcoming revolutionM G Bergeron, M Quellette
Pageof 22